Abstract
Purpose To define clinical and pathological factors predicting reclassification at the time of 1-year repeat biopsy (re-Bx) based on a Japanese cohort forming part of the Prostate Research International: Active Surveillance (PRIAS) study.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have